Skip to main content
Resonetics logo

Resonetics

Nashua, NHFounded 1987

Resonetics provides contract manufacturing services, advanced capabilities, and raw materials for medical devices and components. Headquartered in Nashua, New Hampshire, it operates a global network of facilities focused on specialized manufacturing and product development for the MedTech industry.

Raised
$1.1B
Investors
2
Founded
1987
Employees
1,001–5,000

reccy insights

Recent highlights

Resonetics completed its acquisition of Resolution Medical on Mar 23, 2026, extending its integrated manufacturing capabilities for interventional and neuromodulation markets. The transaction had been announced on Jan 27, 2026, with the company also highlighting potential expansion into structural heart markets. On Jan 6, 2026, Resonetics announced the acquisition of manufacturing assets and process intellectual property from Med-Ally to expand its bioelectronics implant offering. These moves add to a sustained acquisition program: the company’s announced transactions include Memry Corporation in 2023, Agile MV and EaglePicher Technologies’ Medical Power business in 2022, and several medical manufacturing businesses in 2021. Its 2025 acquisitions included Eden Manufacturing and Eden Tool Company. Resonetics also appointed Todd Trapp as chief financial officer in June 2023 and announced a CEO transition plan in May 2023; Kevin D. Kelly is listed as president and CEO. The company reported plans in August 2024 to add 300 positions in Costa Rica over three years.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Resonetics distinct

  1. 01Provides a broad suite of contract manufacturing capabilities, services, and raw materials for medical devices and components.
  2. 02Serves the global MedTech industry through 20 facilities across the United States, Canada, Costa Rica, Israel, Switzerland, and the Netherlands.
  3. 03Facilities specialize in distinct manufacturing or product-development capabilities.
  4. 04Combines precision fabrication processes with product-development support for MedTech customers.

Technology & products6

  • Nitinol Tubing

    Precision-manufactured nitinol tubes in Standard, Precision, and Premium grades for medical device applications requiring specific dimensional tolerances and material properties.

  • Laser Processing

    Custom laser micromachining services including cutting, welding, drilling, ablating, and perforation for complex medical device components and implants.

  • Microfluidic Laminates

    Manufacturing of microfluidic laminate devices for point-of-care diagnostics and lab-on-a-chip applications through automated layering, reagent handling, and laser processing.

Funding

$1.1B disclosed
  • Private EquityDec 2021
    $1.1BLed by The Carlyle Group
  • Private EquityFeb 2018
    Regatta Medical
Latest valuation $2.25 billion2 investors

About Resonetics

Products
Nitinol Tubing, Laser Processing, Microfluidic Laminates, Metal Fabrication, Nitinol Processing, Raw Materials Supply
Leadership
Tom Burns, CEO & DirectorScott Robertson, VPBrett Reynolds, Chief Financial OfficerDavid Rezac, VP, Design and Development Services
Focus areas
Medtech, medical devices, contract manufacturing, medical device components, product development, advanced manufacturing, raw materials, global manufacturing
Headquarters
Nashua, NH
Founded
1987
Employees
1,001–5,000
Patents granted
9
Trademarks
7